SPERO TRINEM INC has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in Israel, Mexico and Taiwan. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ADERIS PHARMACEUTICALS INC, CONCOURSE HEALTH SCIENCES LLC and EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 3 | |
#2 | Mexico | 2 | |
#3 | Taiwan | 2 | |
#4 | United States | 2 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | O'Dowd Hardwin | 4 |
#2 | Perola Emanuele | 3 |
#3 | Grillot Anne-Laure | 3 |
#4 | Bennani Youssef Laafiret | 3 |
#5 | Locher Christopher Phillip | 3 |
#6 | Le Tiran Arnaud | 3 |
#7 | Dean Shannon | 2 |
#8 | Charifson Paul S | 2 |
#9 | Simon Giroux | 1 |
#10 | Odowd Hardwin H | 1 |
Publication | Filing date | Title |
---|---|---|
TW201408681A | Solid forms of (r)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1h-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof | |
US2014045791A1 | Combination therapy to treat Mycobacterium diseases |